Pediatr. praxi 2019; 20(2): 88-92 | DOI: 10.36290/ped.2019.019

Medication of primary headaches

MUDr. Michal Ryzí, Ph.D.
Klinika dětské neurologie LF MU a FN Brno

Children with headache are very frequent patients of general pediatricians. Primary headaches despite benign nature are condition
with significant negative impact on the quality of life of the affected children. Childhood migraine not only has a typical clinical
course that matches a typical range of nosological units, but also requires specific treatment. This article reviews the current
possibilities of classification and acute and profylactic treatment options of primary headaches and differences between child
and adult treatment and diagnostics.

Keywords: headache, classification, treatment, analgesics, triptans

Published: April 23, 2019  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Ryzí M. Medication of primary headaches. Pediatr. praxi. 2019;20(2):88-92. doi: 10.36290/ped.2019.019.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Genizi J, Srugo I, Kerem NC (2013) The cross - ethnic variations in the prevalence of headache and other somatic complaints among adolescents in Northern Israel. J Headache Pain 14: 21. Go to original source... Go to PubMed...
    2. Laurell K, Larsson B, Eeg-Olofsson O. Prevalence of headache in Swedish schoolchildren, with a focus on tension-type headache. Cephalalgia. 2004; 24(5): 380-388. Go to original source... Go to PubMed...
    3. Sillanpää M. Prevalence of headache in prepuberty. Headache: The Journal of Head and Face Pain. 1983; 23(1): 10-14. Go to original source... Go to PubMed...
    4. Headache Classification Committee of the International Headache Society, The International Classification of Headache Disorders. Cephalalgia. 2018; 38 (3rd edition): 1-211. Go to original source...
    5. Hershey AD, Winner P, Kabbouche MA, Gladstein J, Yonker M, et al. (2005) Use of the ICHD-II criteria in the diagnosis of pediatric migraine. Headache 45: 1288-1297. Go to original source...
    6. Trottier ED, Bailey B, Lucas N, Lortie A (2013) Diagnosis of migraine in the pediatric emergency department. Pediatr. Neurol 49: 40-45. Go to original source... Go to PubMed...
    7. Brna P, Dooley J, Gordon K, Dewan T. The prognosis of childhood headache: a 20-year follow-up. Arch. Pediatr. Adolesc. Med. 2005 Dec. 159(12): 1157-1160. Go to original source...
    8. Muchová M. Migréna v dětství a adolescenci - epidemiologie, specifika, terapie. Remedia 2009; 19: 5.
    9. Papetti L, Spalice A, Nicita F, Paolino MC, Castaldo R, et al. (2010) Migraine treatment in developmental age: guidelines update. J Headache Pain 11: 267-276. Go to original source...
    10. Marková M., Kotas R. Primární bolesti hlavy - léčba dnes a zítra. Neurol. praxi 2018; 19(3): 193-198. Go to original source...
    11. Welch KM, Mathew NT, Stone P, et al. Tolerability of sumatriptan: clinical trials and post-marketing experience. Cephalalgia 2000; 20: 687-695. Go to original source... Go to PubMed...
    12. Winner P. Treatment of Migraine in Children and Adolescents in Lipton RB, Bigal ME. Migraine and other headache disorders. New York: Informa, 2006; 375-389.
    13. Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, Korbee LL, Porter LL, Hershey AD; CHAMP Investigators. Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine. N Engl J Med. 2017 Jan 12; 376(2): 115-124. Go to original source...
    14. Lewis DW, Yonker M, Winner P, Sowell M. The treatment of pediatric migraine. Pediatr Ann 2005; 34: 449-460. Go to original source...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.